Literature DB >> 21325349

Iron and vascular calcification. Is there a link?

Ellen Neven1, Tineke M De Schutter, Geert J Behets, Ajay Gupta, Patrick C D'Haese.   

Abstract

Iron deficiency is frequently seen in patients with end-stage renal disease, particularly in those treated by dialysis, this is because of an impairment in gastrointestinal absorption and ongoing blood losses or alternatively, due to an impaired capacity to mobilize iron from its stores, called functional iron deficiency. Therefore, these patients may require intravenous iron to sustain adequate treatment with erythropoietin-stimulating agents. Aside from this, they are also prone to vascular calcification, which has been reported a major contributing factor in the development of cardiovascular disease and the increased mortality associated herewith. Several factors and mechanisms underlying the development of vascular calcification in chronic kidney diseased patients have been put forward during recent years. In view of the ability of iron to exert direct toxic effects and to induce oxidative stress on the one hand versus its essential role in various cellular processes on the other hand, the possible role of iron in the development of vascular calcification should be considered.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325349     DOI: 10.1093/ndt/gfq858

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  15 in total

1.  Quantifying a rare disease in administrative data: the example of calciphylaxis.

Authors:  Sagar U Nigwekar; Craig A Solid; Elizabeth Ankers; Rajeev Malhotra; William Eggert; Alexander Turchin; Ravi I Thadhani; Charles A Herzog
Journal:  J Gen Intern Med       Date:  2014-08       Impact factor: 5.128

2.  Ferric pyrophosphate: good things come to those who wait?

Authors:  Lisa H Fell; Danilo Fliser; Gunnar H Heine
Journal:  Nephrol Dial Transplant       Date:  2015-07-21       Impact factor: 5.992

Review 3.  Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs.

Authors:  Hudaifa Alani; Asad Tamimi; Nihad Tamimi
Journal:  World J Nephrol       Date:  2014-11-06

4.  Anti-platelet factor 4/heparin antibody is associated with progression of peripheral arterial disease in hemodialysis patients.

Authors:  Yen-Hsun Chen; Kao-Chang Lin; Yueh-Feng Tsai; Lai-King Yu; Li-Hsueh Huang; Chien-An Chen
Journal:  Int Urol Nephrol       Date:  2015-07-22       Impact factor: 2.370

5.  Serum ferritin is associated with arterial stiffness in hemodialysis patients: results of a 3-year follow-up study.

Authors:  Kao-Chang Lin; Meng-Yi Tsai; Chun-Ling Chi; Lai-King Yu; Li-Hsueh Huang; Chien-An Chen
Journal:  Int Urol Nephrol       Date:  2015-09-02       Impact factor: 2.370

6.  Serum ferritin is associated with progression of peripheral arterial disease in hemodialysis patients.

Authors:  Chen-Tung Lien; Kao-Chang Lin; Yueh-Feng Tsai; Lai-King Yu; Li-Hsueh Huang; Chien-An Chen
Journal:  Clin Exp Nephrol       Date:  2014-12-24       Impact factor: 2.801

Review 7.  Cutaneous manifestations of ESRD.

Authors:  Timur A Galperin; Antonia J Cronin; Kieron S Leslie
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 8.237

8.  Association between Serum Iron and the Severity of Coronary Artery Disease.

Authors:  Babak Bagheri; Mohammad Shokrzadeh; Vahid Mokhberi; Soheil Azizi; Alireza Khalilian; Negin Akbari; Valiallah Habibi; Keyvan Yousefnejad; Sasan Tabiban; Maryam Nabati
Journal:  Int Cardiovasc Res J       Date:  2013-09-01

9.  Association between dietary iron, iron stores, and serum lipid profile in reproductive age women.

Authors:  Fatemeh Zaribaf; Mohammad Hassan Entezari; Akbar Hassanzadeh; Soheila Mirzaian
Journal:  J Educ Health Promot       Date:  2014-02-21

10.  Resistance to erythropoiesis-stimulating agents is associated with arterial microcalcification in early hemodialysis patients.

Authors:  Hye Sung Won; Su Jin Choi; Yu Seon Yun; Ok-Ran Shin; Yoon Ho Ko; Young Soo Kim; Sun Ae Yoon; Young Ok Kim
Journal:  Biomed Res Int       Date:  2014-03-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.